TNF and colitis: In murine colitis models, the combination of anti‐TNF‐α therapy with NaCr significantly alleviated colitis progression (Figure 7C–I), improved intestinal barrier function (Figure 7J) and enhanced plasma crotonyl‐CoA production compared to NaCr treatment alone (Figure 7K–M).